Vimeo
LinkedIn
Instagram
Share |

ratiopharm

March 18, 2010

Ratiopharm, the generic drug company owned by Germany’s Merckle family, has been sold to Israel-based Teva Pharmaceutical Industries Ltd for an enterprise value of €3.625 billion.

Ratiopharm, the generic drug company owned by Germany's Merckle family, has been sold to Israel-based Teva Pharmaceutical Industries Ltd for an enterprise value of €3.625 billion.

The company, which reported worldwide 2009 revenues of €1.6 billion, is part of the Merckle family's empire that also includes Phoenix Pharmahandel, cement company HeidelbergCement and vehicle manufacturer Kässbohrer.

Click here >>
Close